Korean KOSDAQ biotech Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
08:48
Feb 05
Feb 05
KOSDAQ biotech lacks sector momentum.
KOSDAQ biotech is no longer a group rally: Alteogen's earnings missed, ABL Bio's clinical timeline slipped, and until new global deals or clinical catalysts appear, sector momentum is weak and stock picking is required.
MED
About Korean KOSDAQ biotech Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean KOSDAQ biotech across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Jang Woo-jin.